Skip to main content

Search

News: Communications on Safety

Communications on Safety
Yes

 

 

 

 

Important Medicine Safety Information_Golimumab SIMPONI® 50 mg: Important Changes to the Instructions For Use (IFU) for the SmartJect® Autoinjector/Pre-filled Pen

 

 

 

Important Medicine Safety Information_IMBRUVICA® (IBRUTINIB) - RISK OF FATAL CARDIAC EVENTS

Important Medicines Safety Information_COVID-19 Vaccine Janssen 26 October 2021

Important Announcement: IMBRUVICA

Important Medicine Safety Information_Golimumab SIMPONI® 50 mg: Important Changes to the Instructions For Use (IFU) for the SmartJect® Autoinjector/Pre-filled Pen